news
-
18 September 2017Sonendo® announces growth investment from General Atlantic
Sonendo, Inc., a leading dental technology company, announced today that General Atlantic, a leading global growth equity firm, has made a strategic investment in the company. General Atlantic will be joining existing investors Fjord Ventures, OrbiMed Advisors LLC, Meritech Capital Partners, CVF LLC, and NeoMed to lead the company's latest fundraising round valued at $50 million. In its next phase of growth, Sonendo plans to accelerate ongoing commercialization efforts and further expand and diversify its current product portfolio.
"Sonendo is committed to developing technologies that are transformative and align with our mission of Saving Teeth Through Sound Science®," said Bjarne Bergheim, President, and CEO of Sonendo. "With its strong track record partnering with successful, high-growth companies in the healthcare sectors, General Atlantic is an ideal partner for our next phase of growth."
Founded in 2006 by Fjord Ventures, Sonendo, Inc. is devoted to developing innovative technologies to help dentists save more teeth for more patients. Sonendo's flagship technology, the GentleWave® System, presents an alternative to standard root canal treatment and a departure from the standard file-based method of tissue removal and disinfection for root canals.
"We believe there is a unique opportunity for Sonendo to transform the dental industry with its innovative technology that benefits both dentists and patients alike," said David Caluori of General Atlantic, who will be joining the company's board of directors. "We look forward to partnering with Bjarne and the entire management team to support the company's growth and commitment to developing unique technology intended for a market of underserved consumers and dentists."
Drawing from 37 years of experience investing in over 250 global growth companies, General Atlantic partners with entrepreneurs and management teams who are building leading, high-growth businesses. The firm has $21 billion assets under management as of June 30, 2017. General Atlantic focuses on investments across five sectors, including Internet & Technology, Financial Services, Business Services, Retail & Consumer, and Healthcare, with support from the firm's global team of experts.
General Atlantic has deep expertise in the Healthcare and Technology sectors and is currently invested in leading healthcare companies including Alignment Healthcare, CitiusTech, eviCore Healthcare, Oak Street Health, Ourofino, Sanfer, and Synaptive.
Reed Smith LLP served as legal advisor to Sonendo, and Paul, Weiss, Rifkind, Wharton & Garrison LLP served as legal advisor to General Atlantic.
related
Sonendo® 2017 Red Herring Top 100 North America Winner In Medical Device Category
Sonendo® Acquires Pipstek™ LLC
Sonendo® Closes $35 Million Equity Financing Round
Sonendo® appoints John "Jack" Glenn as Chief Financial Officer
Prospective multicenter study shows remarkable healing rates with Sonendo's Gentlewave® System
Sonendo's GentleWave® System finalist in the 2016 Medical Design Excellence Awards
Sonendo® receives FDA 510(K) clearance for the next generation of the Gentlewave® System
Sonendo® Appoints Chief Commercial Officer
Sonendo® Appoints Vice President of Operations
Sonendo® Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning™System
Sonendo® Closes $35 Million Equity Financing Round
Sonendo® Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning System
Sonendo® Closes $10 Million Venture Debt Facility with Oxford Finance
Sonendo® Receives 510(k) FDA Clearance For Its Multisonic Ultracleaning System™
Sonendo completes second round totaling $27 million
Sonendo® Debuts New Endodontic Multisonic Ultracleaning™ System at AAE 2013 Hawaii
Sonendo Agrees To Terms For Up To $20 Million In Financing